PUMA α Antibodies

Santa Cruz Biotechnology features a diverse variety of PUMA α monoclonal antibodies for advanced research in apoptosis and cell survival pathways. PUMA α Antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PUMA (p53 upregulated modulator of apoptosis) is a pro-apoptotic protein that plays a critical role in the regulation of programmed cell death, particularly in response to cellular stress and DNA damage. By promoting apoptosis, PUMA is essential for maintaining cellular homeostasis and preventing the proliferation of damaged cells, which is crucial in cancer research and therapeutic development. Understanding the function of PUMA α is vital for elucidating the mechanisms of tumorigenesis and developing targeted cancer therapies. PUMA α monoclonal antibodies enable researchers to explore cellular responses to various stress conditions and DNA damage. PUMA α monoclonal antibodies support investigations into cancer biology, cell death mechanisms, and therapeutic resistance. Studying PUMA α expression patterns helps reveal its role in different tissue types and disease states. Santa Cruz Biotechnology monoclonal antibodies for PUMA α contribute to advancing scientific understanding of apoptotic pathways and their potential therapeutic applications.